HOME ABOUT ▾ library contact order ABOUT NEUROAID ▸ CLINIcal studies ▸ safety profile ▸ Medical Professionals
composition & dosage ▸ Find out if neuroaid is right for you ABOUT NeuroAiD is an oral treatment helping victims of strokes and traumatic brain injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapies and exercises. Understanding Prestroke Cognitive Impairment: Key Findings from Mele et al.’s Study

STROKE CLINICAL STUDY HIGHLIGHTS – Prestroke Cognitive Impairment: Frequency and Association With Premorbid Neuropsychiatric, Functional, and Neuroimaging Features by Mele F, Cova I, Nicotra A, et al.

The study by Mele et al. investigates in 474 patients (45% women; mean age 75.5±13.3 years) the prevalence of prestroke cognitive impairment (pre-SCI), diagnosed with the IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly), and its associations with premorbid neuropsychiatric symptoms, functional abilities, and neuroimaging features. Findings indicate that one-third of patients admitted to a stroke unit have pre-SCI that is associated with preexisting neuropsychiatric symptoms and functional performance in daily living. Neuroimaging biomarkers such as white matter lesions and medial temporal lobe atrophy are associated with pre-SCI, suggesting that both small vessel disease and neurodegeneration might be involved in its etiology.

Access the full article at: Mele F, Cova I, Nicotra A, et al. “Prestroke Cognitive Impairment: Frequency and Association With Premorbid Neuropsychiatric, Functional, and Neuroimaging Features.” Stroke. Published online May 31, 2024. https://www.ahajournals.org/doi/10.1161/STROKEAHA.123.045344. This article is licensed under a CC-BY license.